Microdosing candies finally recalled after psychoactive muscimol found
Muscimol, found in the candy, is from hallucinogenic Amanita muscaria mushrooms.
Enlarge (credit: Diamond Shruumz)
After weeks of reports of severe illnesses across the country, the maker of Diamond Shruumz microdosing chocolates, gummies, and candy cones has finally issued a recall. It covers all lots and all flavors of all the brand's products.
The illnesses have been marked by several severe symptoms, which notably include seizures, loss of consciousness, and the need for intubation and intensive care. To date, there have been 39 people sickened, including 23 hospitalizations across 20 states, according to the Food and Drug Administration and the Centers for Disease Control and Prevention. The FDA first issued a warning on the brand's chocolate bars on June 7, when there were reports of eight cases, including six hospitalizations, in four states.
Diamond Shruumz's parent company, Prophet Premium Blends, said in the recall notice that it had received only two complaints about the products to date and, upon receiving those complaints, reviewed recent laboratory analyses (Certificates of Analysis) of its products. According to the company, those CoAs noted "higher than normal amounts of muscimol," which is one of two key compounds found in hallucinogenic Amanita mushrooms. Muscimol "could be a potential cause of symptoms consistent with those observed in persons who became ill after eating Diamond Shruumz products," the company said in the recall notice.